N@N

DBA, DBE, ZN, HYG, FOLD, PIP Are Seasonally Ripe To Go Down In the Next Five Weeks

October 17, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of PowerShares DB Agriculture Fund (NYSE:DBA), PowerShares DB Energy Fund (NYSE:DBE), Zion Oil & Gas Inc. (NASDAQ:ZN), iShares iBoxx $ High Yield Corporate Bond Fund (NYSE:HYG), Amicus Therapeutics Inc. (NASDAQ:FOLD), PharmAthene, Inc. (NYSE:PIP) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  DBA     PowerShares DB Agriculture Fund  -2.22%           88.89% (8 of 9)      Tuesday, November 15th 2016
  DBE     PowerShares DB Energy Fund       -1.56%           100.00% (9 of 9)     Wednesday, October 19th 2016
  ZN      Zion Oil & Gas Inc.              -9.28%           88.89% (8 of 9)      Tuesday, November 29th 2016
  HYG     iShares iBoxx $ High Yield Corporate Bond Fund  -1.27%           88.89% (8 of 9)      Wednesday, November 16th 2016
  FOLD    Amicus Therapeutics Inc.         -5.53%           88.89% (8 of 9)      Thursday, October 20th 2016
  PIP     PharmAthene, Inc.                -15.58%          81.82% (9 of 11)     Tuesday, November 15th 2016

PowerShares DB Agriculture Fund (NYSE:DBA) - PowerShares DB Agriculture Fund.

PowerShares DB Energy Fund (NYSE:DBE) - PowerShares DB Energy Fund.

Zion Oil & Gas Inc. (NASDAQ:ZN) - Zion Oil & Gas, Inc. engages in the exploration of oil and gas properties in Israel. It primarily holds the Megiddo-Jezreel petroleum exploration license that covers an area of approximately 99,000 acres located on onshore Israel. The company was founded in 2000 and is based in Dallas, Texas..

iShares iBoxx $ High Yield Corporate Bond Fund (NYSE:HYG) - iShares iBoxx High Yield Corporate Bond Fund.

Amicus Therapeutics Inc. (NASDAQ:FOLD) - Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its principal product is the migalastat HCl, a small molecule, which has completed Phase III studies that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease. The company is also developing SD-101, which is in Phase III clinical study for the treatment of the genetic connective tissue disorder epidermolysis bullosa; ATB200 that is in Phase II studies to treat pompe disease; AT2221, which is in Phase II studies for the treatment of pompe disease; and AT3375 to treat Parkinson's disease. The company has strategic alliance with GlaxoSmithKline plc to develop and commercialize migalastat as a monotherapy and in combination with ERT for Fabry disease. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey..

PharmAthene, Inc. (NYSE:PIP) - PharmAthene, Inc., a biodefense company, develops and commercializes medical counter measures against biological and chemical threats in the United States. The company focuses on developing lyophilized anthrax vaccines based on DepoVax, a proprietary technology platform that contributes recombinant protective antigen bulk drug substance. It serves National Institute of Allergy and Infectious Diseases, and the Biomedical Advanced Research and Development Authority. The company has a license agreement with ImmunoVaccine Technologies for the use of the DepoVax vaccine platform to develop an anthrax vaccine. PharmAthene, Inc. is headquartered in Annapolis, Maryland..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources

---